ARCHIVES

Lung Cancer Clinical Trials Cost-Effective Alternative

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979